Heron Therapeutics
HRTX
#7833
Rank
C$0.34 B
Marketcap
$2.27
Share price
3.27%
Change (1 day)
-4.39%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.68. In 2022 the company made an earnings per share (EPS) of -$2.48 an increase over its 2021 EPS that were of -$3.23.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-36.43%
2022-$2.48-23.11%
2021-$3.23-10%
2020-$3.59-0%
2019-$3.591.21%
2018-$3.55-32.7%
2017-$5.27-19.34%
2016-$6.5354.76%
2015-$4.221.73%
2014-$4.15-16.23%
2013-$4.9591.67%
2012-$2.58-31.45%
2011-$3.77-27.06%
2010-$5.17-43.75%
2009-$9.19-57.33%
2008-$21.54-82.92%
2007-$126.0720.61%
2006-$104.53175.76%
2005-$37.91-21.43%
2004-$48.25100%
2003-$24.12-38.24%
2002-$39.06161.54%
2001-$14.93-106.46%
2000$231.032051.55%
1999$10.74839.73%
1998$1.14-105.48%
1997-$20.87-88.16%
1996-$176.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.87-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.34 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.25-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.37 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA